-
Aglaia Oncology Funds and Sinzer - Grant Thornton Launch Dedicated Life Sciences Impact Measuring and Reporting Suite
b3cnewswire
December 25, 2019
Dutch life sciences investor Aglaia Oncology Funds, officially launches its ‘Life Sciences Impact Suite’, a groundbreaking tool enabling measurement and reporting of the social impact realized by investments ...
-
Survey finds smaller enterprises will drive life sciences in Scotland
europeanpharmaceuticalreview
December 18, 2019
Researchers have revealed that small- and medium-sized companies will by key in the growth of the life sciences sector in Scotland.
-
Brexit will have ‘minimal’ impact on R&D, expert says
europeanpharmaceuticalreview
April 08, 2019
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK…
-
CAC and rfxcel Announce a Partnership Agreement for Pharmaceutical Traceability
b3cnewswire
February 28, 2019
CAC Corporation (Head Office: Chuo-ku, Tokyo; President and CEO: Ryota Nishimori; hereinafter called "CAC") has signed a partnership agreement with ....
-
AKLRD awarded £675,000 grant from Innovate UK
pharmaceutical-technology
February 19, 2019
The UK Government’s innovation agency Innovate UK has awarded AKL Research and Development (AKLRD) £675,000 linked to the potential of its investigational medicine APPA for osteoarthritis......
-
Jazz Pharmaceuticals Announces Board of Directors Appointment
americanpharmaceuticalreview
February 18, 2019
Jazz Pharmaceuticals announced Anne O'Riordan, Senior Managing Director, Life Sciences of Accenture, was appointed to its Board of Directors...
-
Bruntwood to make £10M life science investment
pharmatimes
December 20, 2018
Bruntwood SciTech has announced a £10 million investment into the life sciences sector, in the form of 50,000 square feet of office space and laboratory facilities in Alderley Park, Cheshire.
-
Amgen Golden Tickets provide startup companies with free lab space to further advance innovative science and technology
worldpharmanews
December 19, 2018
Amgen and LabCentral today announced that Kernal Biologics and PanTher Therapeutics have each won the Amgen Golden Ticket at LabCentral.
-
Pierre Fabre to launch blockchain patient engagement pilot
pharmaphorum
December 18, 2018
Pierre Fabre Pharmaceuticals has joined a blockchain consortium that allows patients to share real-time digital health data to inform late-stage clinical research.
-
Avacta, LG Chem Life Sciences Agree Multi-Target Affimer Therapeutics Development Alliance
americanpharmaceuticalreview
December 17, 2018
Avacta and LG Chem Life Sciences announced a multi-target collaboration and development agreement. The agreement provides LG Chem with .....